Stay updated on Cabozantinib Combo With Atezolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib Combo With Atezolizumab in Solid Tumors Clinical Trial page.

Latest updates to the Cabozantinib Combo With Atezolizumab in Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedGastric cancer was added to the list of included conditions. The page revision was updated from v3.4.1 to v3.4.2.SummaryDifference0.0%

- Check18 days agoChange DetectedThe page shows a revision update from v3.4.0 to v3.4.1 with no visible changes to study details or user-facing content.SummaryDifference0.0%

- Check32 days agoChange DetectedUI text updates include adding Show glossary and Hide glossary controls, capitalization tweaks to labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and a new revision note 'Revision: v3.4.0'. These changes are minor and do not affect study content or functionality; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No substantive study content or functionality appears to be affected.SummaryDifference0.0%

- Check68 days agoChange DetectedLocations were updated to add numerous new sites across the United States, Australia, Spain, the United Kingdom, Italy, Germany, and other regions, while several existing sites were removed. The revision is noted as v3.3.3.SummaryDifference2%

- Check90 days agoChange DetectedPublications are now described as automatically populated from PubMed and may not all pertain to the study, and a revision tag for v3.3.2 has been added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Cabozantinib Combo With Atezolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib Combo With Atezolizumab in Solid Tumors Clinical Trial page.